Biotech and Money Inv€$tival Showcase in partnership with Jefferies

FreeMind is a proud supporter of the upcoming Inv€$tival Showcase

Where: London, UK
When: November 14, 2017

Showcasing innovative investable Biotech, Medtech and Digital Health investment and partnering opportunities.

Biotech and Money connects corporates to capital, and the Inv€$tival Showcase is our most direct way of showcasing the latest investable private and public life science opportunities to our growing investor network, and that of our partners, Jefferies LLC.

The 4 track Inv€$tival Showcase is designed to highlight the latest innovative companies who are looking to raise capital and their profile amongst investors, and provide an unparalled opportunity for 1-2-1 investor and B2B meetings in a unique setting, and as part of the week of the Jefferies Global Healthcare conference in London. The 4 tracks are split into industry sub-sectors, with sections for companies working within the fields of immuno-oncology, cell and gene therapy, precision medicine, neuroscience / CNS, orphan drugs, digital health and medical devices, as well as an agnostic section for other industry sub-sectors. Presenting companies will range from the latest start-ups through to growing public companies, delivering succinct powerful presentations to an audience of qualified investors.

The MedTech Conference Powered by AdvaMed

FreeMind is pleased to support The MedTech Conference powered by AdvaMed

Where: San Jose, CA
When: September 25-27, 2017

The MedTech Conference powered by AdvaMed is the leading gathering in North America of global medtech executives with regulatory, reimbursement, business development, legal, IP, marketing, quality, compliance, HR and other key responsibilities. Along with industry leaders, the international conference attracts business development professionals, investors, policy-makers, members of the media, legal experts, consultants, distributors, and other important stakeholders.

More than 2,500 attendees will network, conduct business, gain access to capital and share insights in San Jose, California from September 25-27. The conference also features world-class plenary speakers, networking, and business development opportunities. Visit www.themedtechconference.com to learn more.

 

#BIO2017 Grants’ Winners!

We all had an amazing week in San Diego, seeing hundreds of new and familiar faces!

FreeMind was quite pleased to give away 5 bottles of Grants Whisky this year and we look forward to helping our clients win hundreds of thousands of dollars in governments grants before the year is out.

Two lucky winners: Mary Syto, Director, Clinical Operations at Receptos and

Sam Mercer, Director of Outsourcing and Business Development at Eupraxia Pharmaceuticals.

Investment for Advanced Therapies – May 3, 2017

FreeMind is proud to support the upcoming Investment for Advanced Therapies event!

When: May 3, 2017
Where: London, UK

Investment for Advanced Therapies will be the C-Level meeting place for heavyweight investors, analysts, biotechs, venture partners and industry experts who are driving the industry forward. Don’t miss your chance to shape the future and put your company on the map!

This one-day, highly interactive program will:

• Explain the market outlook and address specific questions regarding investment and licensing opportunities in advanced therapies

• Provide institutional, strategic and venture investors with unique insight into financing hypothesis for advanced therapies

• Showcase a cross section of early stage, pre-IPO, late stage and public biotech companies and provide extensive networking opportunities

• Introduce senior executives from biopharmaceutical companies to explain how investors can profit from the development of the advanced therapies franchise

• Promote and facilitate investment, financing, partnerships and deal making in
the cell and gene therapy field

Visit here for more information.

MedFIT – Fostering Innovation in medTech

FreeMind is pleased to support the upcoming MedFIT event!
 
Where: Grenoble, France
When: June 28-29, 2017
 
A 360° approach to build innovation partnerships, source licensing deals and accelerate market access in medtech.
 
Organised by Eurasanté and the NHL Cluster, with the support of Medicalps and Alsace BioValley, the 1st edition of MedFIT will gather 500 participants with 50% international actors (medtech and diagnostics companies and start-ups, TTOs, academia, R&D services companies and investors) who will have the opportunity to meet potential investors and partners from both academia and industry.
 
MedFIT combines:

  • Pre-qualified one to one meetings to help you meet up to 30 potential partners over two days
  • Round table discussions and conferences to discuss trending topics in the medical technologies and diagnostics sector
  • Start-up slams to promote less than 5-year old company innovations
  • Exhibition area to enhance your visibility
  • Informal networking event

 
Contact :
Anaïs Schoreel
Business Developer
Ligne directe : +33 (0)3 59 39 01 81
[email protected]
 
Website : www.medfit-event.com
Registration : www.medfit-event.com/register-and-plan/registration-fees/

BioTrinity 2017

The FreeMind Group is proud to support the upcoming BioTrinity conference!

Where: London, UK

When: May 8-10, 2017

BioTrinity is one of Europe’s leading biopartnering and investment conferences, and the largest of its type in the UK.

Now in its 11th year, the aim of BioTrinity is simple – create an ideal networking and partnering platform for life science companies across the world to meet all under one roof and catalyse business in the industry, to ultimately help shape our healthcare future.

BioTrinity offers unique access to global life science investors, big pharma executives and innovative CEO’s of emerging R&D companies seeking to make deals and grow their networks.

,

NDFS12 – FreeMind Group Opening Remarks

Ram May-Ron of the FreeMind Group opens the 12th Annual Non-Dilutive Funding Summit with a few remarks on recent trends in life science R&D funding and the importance of federal grants as a strategic source of funds.

,

12th Annual Non-Dilutive Funding Summit Keynote Address

Dr. Ronald Hann of the Defense Threat Reduction Agency (DTRA) presents the keynote address on Preparing for the Unthinkable.

 

View Slide Deck

,

NDFS12 – BARDA Presentation: CARB-X: A Novel Non-Dilutive Partnership to Promote Innovation and Foster a Robust Antimicrobials Pipeline

Tyler Merkeley of the Biomedical Advanced Research and Development Authority (BARDA) CARB-X program talks about the novel non-dilutive partnership created to promote innovation and foster a robust antimicrobials pipeline.

 

View Slide Deck